Cocrystal Pharma, Inc.
COCP · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $13,739 | $15,159 | $14,447 | $20,551 |
| - Cash | $7,729 | $4,766 | $6,921 | $9,860 |
| + Debt | $1,583 | $1,658 | $1,733 | $1,806 |
| Enterprise Value | $7,593 | $12,051 | $9,259 | $12,497 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$13 | -$21 | -$1,360 | -$28 |
| % Margin | – | – | – | – |
| EBITDA | -$2,036 | -$2,087 | -$2,316 | -$3,238 |
| % Margin | – | – | – | – |
| Net Income | -$2,049 | -$2,055 | -$2,301 | -$3,266 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.19 | -0.2 | -0.23 | -0.32 |
| % Growth | 5% | 13% | 28.1% | – |
| Operating Cash Flow | -$1,549 | -$2,155 | -$2,939 | -$3,160 |
| Capital Expenditures | -$13 | $0 | $0 | $0 |
| Free Cash Flow | -$1,561 | -$2,155 | -$2,939 | -$3,160 |